Tochi M Okwuosa
Overview
Explore the profile of Tochi M Okwuosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okwuosa T, Lloyd-Jones D
JACC CardioOncol
. 2024 Oct;
6(5):758-760.
PMID: 39479319
No abstract available.
2.
Addison D, Neilan T, Barac A, Scherrer-Crosbie M, Okwuosa T, Plana J, et al.
Circulation
. 2023 Sep;
148(16):1271-1286.
PMID: 37732422
Advances in cancer therapeutics have led to dramatic improvements in survival, now inclusive of nearly 20 million patients and rising. However, cardiovascular toxicities associated with specific cancer therapeutics adversely affect...
3.
Golemi L, Sharma A, Sarau A, Varandani R, Seder C, Okwuosa T
Cardiol Res
. 2023 Jun;
14(3):237-239.
PMID: 37304916
Background: Most studies have compared post-treatment electrocardiogram (ECG) abnormalities in cancer patients to the general population. To assess baseline cardiovascular (CV) risk, we compared pre-treatment ECG abnormalities in cancer patients...
4.
Beavers C, Rodgers J, Bagnola A, Beckie T, Campia U, Di Palo K, et al.
Circulation
. 2022 Mar;
145(15):e811-e838.
PMID: 35249373
In the cardio-oncology population, drug interactions are of particular importance given the complex pharmacological profile, narrow therapeutic index, and inherent risk of therapies used to manage cardiovascular disease and cancer....
5.
Pre-Diagnosis Exercise and Cardiovascular Events in Primary Breast Cancer: Women's Health Initiative
Okwuosa T, Ray R, Palomo A, Foraker R, Johnson L, Paskett E, et al.
JACC CardioOncol
. 2021 Aug;
1(1):41-50.
PMID: 34396161
Objectives: The purpose of this study was to investigate whether pre-diagnosis exercise reduces the risk of subsequent cardiovascular events (CVEs) in women with primary breast cancer. Background: Cardiovascular disease (CVD)...
6.
Zimmerman A, Planek M, Chu C, Oyenusi O, Paner A, Reding K, et al.
Cardiovasc Endocrinol Metab
. 2021 Jun;
10(2):62-71.
PMID: 34113793
Cardiovascular disease is one of the leading causes of morbidity and mortality in persons with cancer. The elevated risk is thought to derive from the combination of cardiovascular risk factors...
7.
Okwuosa T, Morgans A, Rhee J, Reding K, Maliski S, Plana J, et al.
Circ Genom Precis Med
. 2021 Apr;
14(3):e000082.
PMID: 33896190
Cardiovascular disease and cancer are the leading causes of death in the United States, and hormone-dependent cancers (breast and prostate cancer) are the most common noncutaneous malignancies in women and...
8.
Brann A, Bai C, Hibbeln J, Williams K, Okwuosa T
Cardiooncology
. 2021 Feb;
2(1):7.
PMID: 33530143
Background: The presence and burden of coronary artery calcium (CAC) is a strong predictor of cardiovascular events. In an effort to gain insight into the utility of CAC for coronary...
9.
Prabhu N, Kapur N, Catalona W, Leikin R, Helenowski I, Jovanovich B, et al.
Urol Oncol
. 2020 Nov;
39(2):130.e9-130.e15.
PMID: 33132024
Background: Multiple studies have investigated the role of statins in prostate cancer (CaP), the leading cause of cancer related death in men. Retrospective cohort studies investigating the correlation between statin...
10.
Brown S, Okwuosa T, Barac A, Volgman A
J Am Heart Assoc
. 2020 Jan;
9(2):e015327.
PMID: 31960742
No abstract available.